CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
58.85
0.34%
Market Trading Hours* (UTC) Opens on Thursday at 07:00

Mon - Fri: 07:00 - 15:30

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.30
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.022102 %
Charges from full value of position ($-4.20)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.022102%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.000121 %
Charges from full value of position ($-0.02)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.000121%
Overnight fee time 21:00 (UTC)
Min traded quantity 0.1
Currency EUR
Margin 5%
Stock exchange France
Commission on trade 0%

*Information provided by Capital.com

Eurofins Scientific SE ESG Risk Ratings

High Medium Low Negligible

‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

More ESG coverage

Key Stats
Prev. Close* 59.05
Open* 58.8
1-Year Change* -4.85%
Day's Range* 58.75 - 59.45
52 wk Range 44.83-72.12
Average Volume (10 days) 249.16K
Average Volume (3 months) 6.97M
Market Cap 10.75B
P/E Ratio 21.47
Shares Outstanding 192.19M
Revenue 6.51B
EPS 2.59
Dividend (Yield %) 1.79598
Beta 0.40
Next Earnings Date N/A

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 16, 2024 59.05 -0.65 -1.09% 59.70 59.85 58.85
Apr 15, 2024 60.55 1.00 1.68% 59.55 61.35 59.55
Apr 12, 2024 59.65 -0.95 -1.57% 60.60 61.00 59.50
Apr 11, 2024 60.10 0.50 0.84% 59.60 60.65 59.35
Apr 10, 2024 60.05 -0.55 -0.91% 60.60 61.90 59.80
Apr 9, 2024 60.05 0.85 1.44% 59.20 61.05 59.00
Apr 8, 2024 59.35 1.35 2.33% 58.00 59.40 58.00
Apr 5, 2024 58.60 -1.65 -2.74% 60.25 60.60 58.10
Apr 4, 2024 61.15 1.00 1.66% 60.15 61.65 60.10
Apr 3, 2024 60.25 0.35 0.58% 59.90 60.30 59.45
Apr 2, 2024 59.80 1.10 1.87% 58.70 60.05 58.20
Mar 28, 2024 58.80 1.65 2.89% 57.15 58.95 57.15
Mar 27, 2024 57.15 0.65 1.15% 56.50 57.15 56.35
Mar 26, 2024 56.50 0.90 1.62% 55.60 56.75 55.60
Mar 25, 2024 55.70 -0.50 -0.89% 56.20 57.20 55.70
Mar 22, 2024 55.90 0.00 0.00% 55.90 56.20 55.70
Mar 21, 2024 56.05 -0.25 -0.44% 56.30 56.35 55.70
Mar 20, 2024 55.85 -0.35 -0.62% 56.20 56.70 55.65
Mar 19, 2024 56.45 0.65 1.16% 55.80 56.45 55.65
Mar 18, 2024 55.75 -0.30 -0.54% 56.05 56.20 55.60

Eurofins Scientific Events

Time (UTC) Country Event
Wednesday, April 24, 2024

Time (UTC)

05:15

Country

LU

Event

Q1 2024 Eurofins Scientific SE Trading Statement Release
Q1 2024 Eurofins Scientific SE Trading Statement Release

Forecast

-

Previous

-

Time (UTC)

13:00

Country

LU

Event

Q1 2024 Eurofins Scientific SE Trading Statement Call
Q1 2024 Eurofins Scientific SE Trading Statement Call

Forecast

-

Previous

-
Thursday, April 25, 2024

Time (UTC)

10:59

Country

LU

Event

Eurofins Scientific SE Annual Shareholders Meeting
Eurofins Scientific SE Annual Shareholders Meeting

Forecast

-

Previous

-
Wednesday, July 24, 2024

Time (UTC)

05:15

Country

LU

Event

Half Year 2024 Eurofins Scientific SE Earnings Release
Half Year 2024 Eurofins Scientific SE Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 6712.1 6717.7 5438.8 4562.8 3781.15
Revenue 6712.1 6717.7 5438.8 4562.8 3781.15
Cost of Revenue, Total 5199.1 4816 4026.1 3632.1 3061.3
Gross Profit 1513 1901.7 1412.7 930.7 719.845
Total Operating Expense 5675.2 5244.9 4415.2 3989.3 3260.39
Selling/General/Admin. Expenses, Total 0 0 0
Depreciation / Amortization 476 428.9 389.1 357.2 199.085
Other Operating Expenses, Total 0.1
Operating Income 1036.9 1472.8 1023.6 573.5 520.76
Interest Income (Expense), Net Non-Operating -120.9 -97 -97.5 -93.2 -59.717
Other, Net -12.3 -7 -5.9 -3.1 -0.001
Net Income Before Taxes 903.7 1368.8 920.2 477.2 461.042
Net Income After Taxes 683 1043.4 707.2 360.3 356.061
Minority Interest 4.4 -0.4 -1 0 0.358
Net Income Before Extra. Items 687.4 1043 706.2 360.3 356.419
Total Extraordinary Items -77.3 -260 -166.7 -165 -132.476
Net Income 610.1 783 539.5 195.3 223.943
Total Adjustments to Net Income -29.2 -34.5 -34.2 -49.8 -48.624
Income Available to Common Excl. Extra. Items 658.2 1008.5 672 310.5 307.795
Income Available to Common Incl. Extra. Items 580.9 748.5 505.3 145.5 175.319
Dilution Adjustment 0
Diluted Net Income 580.9 748.5 505.3 145.5 175.319
Diluted Weighted Average Shares 199 200.6 195.9 186 183.01
Diluted EPS Excluding Extraordinary Items 3.30754 5.02742 3.43032 1.66935 1.68185
Dividends per Share - Common Stock Primary Issue 1 1 0.68 0 0.288
Diluted Normalized EPS 3.51224 5.02742 3.43032 1.66935 1.68185
Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
Total revenue 3209.5 3300.6 3411.5 3445.4 3272.3
Revenue 3209.5 3300.6 3411.5 3445.4 3272.3
Cost of Revenue, Total 2569.9 2616.8 2582.3 2551.8 2264.2
Gross Profit 639.6 683.8 829.2 893.6 1008.1
Total Operating Expense 2813 2865.5 2809.7 2785.9 2459
Selling/General/Admin. Expenses, Total 0 0 0 0 0
Depreciation / Amortization 243 248.6 227.4 234.1 194.8
Operating Income 396.5 435.1 601.8 659.5 813.3
Interest Income (Expense), Net Non-Operating -42.3 -63.4 -69.8 -54.4 -49.6
Net Income Before Taxes 354.3 371.7 532 605.1 763.7
Net Income After Taxes 261 287.2 395.8 460.5 582.9
Minority Interest 0.8 2.7 1.7 0 -0.4
Net Income Before Extra. Items 261.8 289.9 397.5 460.5 582.5
Total Extraordinary Items -110.3 10.5 -87.8 -93.1 -166.9
Net Income 151.5 300.4 309.7 367.4 415.6
Total Adjustments to Net Income -26.8 -11.2 -18 -16.3 -18.2
Income Available to Common Excl. Extra. Items 235 278.7 379.5 444.2 564.3
Income Available to Common Incl. Extra. Items 124.7 289.2 291.7 351.1 397.4
Diluted Net Income 124.7 289.2 291.7 351.1 397.4
Diluted Weighted Average Shares 198.2 198 200 200.2 201
Diluted EPS Excluding Extraordinary Items 1.18567 1.40758 1.8975 2.21878 2.80746
Dividends per Share - Common Stock Primary Issue 0 1 0 1 0
Diluted Normalized EPS 1.23027 1.55977 1.8975 2.21878 2.80746
Other Operating Expenses, Total 0.1 0.1
Other, Net 0.1
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 2313.3 2319 2518.2 1604.1 1705.4
Cash and Short Term Investments 486.6 515.3 912.4 297 506.246
Cash 432.2 497.9 903.7 293.4 24.599
Cash & Equivalents 54.4 17.4 8.7 3.6 481.647
Total Receivables, Net 1597.3 1581 1389.1 1185 1043.32
Accounts Receivable - Trade, Net 1341.7 1389.2 1193.5 1001.2 807.233
Total Inventory 145.6 154.2 157 79.3 66.373
Prepaid Expenses 78.3 68 59.6 42.6 42.668
Other Current Assets, Total 5.5 0.5 0.1 0.2 46.796
Total Assets 10083.5 9332.3 8575.5 7823.1 7205.45
Property/Plant/Equipment, Total - Net 2167.7 1829.9 1574.9 1593.5 1018.01
Property/Plant/Equipment, Total - Gross 4736.7 4020.7 3344.9 3171.5 2151.32
Accumulated Depreciation, Total -2569.1 -2190.8 -1769.9 -1578 -1133.31
Goodwill, Net 4524.1 4115.1 3524.1 3608.8 3418.33
Intangibles, Net 919.1 895.7 825.1 918.2 946.918
Long Term Investments 83.6 81.7 56.6 54.5 72.626
Other Long Term Assets, Total 75.7 90.9 76.6 44 44.169
Total Current Liabilities 1772.2 1855.7 1696.4 1581.6 1450.66
Payable/Accrued -0.1
Accrued Expenses 843.7 874.6 796.6 623.7 560.803
Notes Payable/Short Term Debt 78.4 80.3 16.9 319.5 372.243
Current Port. of LT Debt/Capital Leases 135.4 173.5 220.7 135.3 18.832
Other Current Liabilities, Total 367.3 404.4 383.4 271.6 266.84
Total Liabilities 5301.4 4684.6 4885.2 4984.5 4536.26
Total Long Term Debt 3111.8 2500.3 2917.2 3086.9 2766.17
Long Term Debt 2712.8 2082.1 2502.4 2646.8 2727.22
Capital Lease Obligations 399 418.2 414.8 440.1 38.946
Deferred Income Tax 133.6 123.6 115.3 124.5 138.557
Minority Interest 68.9 29.5 26.1 59.5 52.992
Other Liabilities, Total 214.9 175.5 130.2 132 127.88
Total Equity 4782.1 4647.7 3690.3 2838.6 2669.19
Common Stock 1.9 1.9 1.9 1.8 1.775
Retained Earnings (Accumulated Deficit) 3925.9 3542.7 2853.1 1697.1 1614.03
Other Equity, Total 868.5 1106.7 835.3 1139.9 1053.57
Total Liabilities & Shareholders’ Equity 10083.5 9332.3 8575.5 7823.1 7205.45
Total Common Shares Outstanding 192.52 192.214 190.794 179.035 177.522
Accounts Payable 347.4 322.9 278.9 231.5 231.942
Treasury Stock - Common -14.2 -3.6 0 -0.2 -0.184
Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
Total Current Assets 2584.9 2313.3 2706.7 2319 2412.9
Cash and Short Term Investments 686.4 486.6 718.8 515.3 639.9
Cash & Equivalents 686.4 486.6 718.8 515.3 639.9
Total Receivables, Net 1504.2 1477.3 1594.3 1465.9 1405.3
Accounts Receivable - Trade, Net 1356.3 1341.7 1471.5 1389.2 1316
Total Inventory 150.3 145.6 159.2 154.2 169.1
Prepaid Expenses 237.6 198.3 231.7 183.1 198.4
Other Current Assets, Total 6.4 5.5 2.7 0.5 0.2
Total Assets 10317.9 10083.5 10260.8 9332.3 8661
Property/Plant/Equipment, Total - Net 2207.1 2167.7 1975.6 1829.9 1667.3
Goodwill, Net 4519.7 4524.1 4453.6 4115.1 3643.3
Intangibles, Net 853.3 919.1 971.1 895.7 814.9
Long Term Investments 80.4 83.6 82.7 81.7 61.5
Other Long Term Assets, Total 72.5 75.7 71.1 90.9 61.1
Total Current Liabilities 1801.8 1772.2 2032.1 1855.7 1758.1
Payable/Accrued 564.8 647.7 590.3 627.6 530.8
Accrued Expenses 77.6 38 39.3 31.4 44.4
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 145.7 213.8 261.3 253.8 128.2
Other Current Liabilities, Total 1013.7 872.7 1141.2 942.9 1054.7
Total Liabilities 5317.7 5301.4 5563.3 4684.6 4581.8
Total Long Term Debt 3128.9 3111.8 3084.5 2500.3 2526.8
Long Term Debt 3128.9 3111.8 3084.5 2500.3 2526.8
Deferred Income Tax 128.8 133.6 162.4 123.6 116.2
Minority Interest 67.5 68.9 69.8 29.5 31
Other Liabilities, Total 190.7 214.9 214.5 175.5 149.7
Total Equity 5000.2 4782.1 4697.5 4647.7 4079.2
Common Stock 1.9 1.9 1.9 1.9 1.9
Retained Earnings (Accumulated Deficit) 3861.2 3925.9 3613.4 3542.7 3132.2
Other Equity, Total 1184.7 868.5 1094 1106.7 945.1
Total Liabilities & Shareholders’ Equity 10317.9 10083.5 10260.8 9332.3 8661
Total Common Shares Outstanding 192.191 192.52 192.338 192.214 191.329
Treasury Stock - Common -47.6 -14.2 -11.8 -3.6
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 780 1056.6 694.4 271.5 289.84
Cash From Operating Activities 1136.2 1511.5 1223.5 677.8 543.894
Cash From Operating Activities 504.4 450.7 426 395.9 223.747
Non-Cash Items 12.2 227.4 142.8 69.6 41.124
Cash Taxes Paid 296.1 296.7 94 95 67.816
Cash Interest Paid 49.4 168.8 67.8 93.3 59.983
Changes in Working Capital -264.9 -315.1 -142.5 -159.2 -88.622
Cash From Investing Activities -855.9 -1021 -525 -540.2 -1557.45
Capital Expenditures -660.2 -506.4 -355.5 -425.1 -364.449
Other Investing Cash Flow Items, Total -195.7 -514.6 -169.5 -115.1 -1193
Cash From Financing Activities -311.3 -910.3 -48.6 -342.2 691.064
Financing Cash Flow Items -502.9 -205.6 -104.5 -461.9 -108.706
Total Cash Dividends Paid -192.1 -129.8 -51.1 -42.645
Issuance (Retirement) of Stock, Net -1.2 32.2 564.8 23.4 20.041
Issuance (Retirement) of Debt, Net 384.9 -607.1 -508.9 147.4 822.374
Foreign Exchange Effects -0.8 24.3 -33.9 4.1 1.465
Net Change in Cash -31.8 -395.5 616 -200.5 -321.023
Amortization 104.5 91.9 102.8 100 77.805
Dec 2022 Jun 2022 Dec 2021 Jun 2021
Net income/Starting Line 780 423.9 1056.6 578.8
Cash From Operating Activities 1136.2 468.1 1511.5 708.6
Cash From Operating Activities 504.4 240 450.7 204.4
Non-Cash Items 116.7 86.6 319.3 192.8
Cash Taxes Paid 296.1 179.4 296.7 139.9
Cash Interest Paid 49.4 14.5 168.8 135.8
Changes in Working Capital -264.9 -282.4 -315.1 -267.4
Cash From Investing Activities -855.9 -474.6 -1021 -276.5
Capital Expenditures -660.2 -289.5 -506.4 -223
Other Investing Cash Flow Items, Total -195.7 -185.1 -514.6 -53.5
Cash From Financing Activities -311.3 168.2 -910.3 -718.7
Financing Cash Flow Items -502.9 -342.2 -205.6 -150.4
Total Cash Dividends Paid -192.1 -129.8 -0.4
Issuance (Retirement) of Stock, Net -1.2 -0.3 32.2 12.6
Issuance (Retirement) of Debt, Net 384.9 510.7 -607.1 -580.5
Foreign Exchange Effects -0.8 39.3 24.3 14.7
Net Change in Cash -31.8 201 -395.5 -271.9

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Eurofins Company profile

Eurofins Scientific is an international laboratory testing company, founded in 1987 and headquartered in Luxembourg. Through its subsidiaries, the company offers environmental, pharmaceutical products and food testing, as well as the key emerging specialty clinical diagnostic testing.

The company prides itself on performing over 400 million tests each year and holding over 200,000 validated analytical methods in its portfolio. With over 45,000 employees, Eurofins Scientific operates a global network of 800 laboratories in 47 countries.

Eurofins operates through an extensive network of laboratories, including Institut Nehring GmbH in Germany, VRL Laboratories in the United States, Agfirst Bay of Plenty, a fruit maturity testing laboratory in New Zealand, and Megalab SA, a clinical diagnostic laboratory in Spain. Eurofins also have subsidiaries in Eastern Canada, Brazil, and Japan.

One of the fastest-growing companies in Europe, Eurofins Scientific is known for its aggressive expansion strategy, as it has bought more than 80% of its competitors worldwide. Since it went public in 1997 on the French stock exchange, Eurofins has been reporting a 35% growth in sales each year with 3.7 billion Euro in 2018.

The Eurofins share price is quoted on Euronext Paris and featured in the CAC Mid 60 Index. Find out an updated Eurofins company profile, the latest company news and the most current Eurofins share price data at Capital.com.

Industry: Healthcare Facilities & Services (NEC)

23 Val Fleuri
LUXEMBOURG
1526
LU

Income Statement

  • Annual
  • Quarterly

News

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024

How escalating geopolitical tensions are impacting oil markets

The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

13:34, 4 April 2024

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

People also watch

ETH/USD

3,004.32 Price
-2.310% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

US100

17,507.60 Price
-1.250% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

Gold

2,372.05 Price
-0.450% 1D Chg, %
Long position overnight fee -0.0191%
Short position overnight fee 0.0109%
Overnight fee time 21:00 (UTC)
Spread 0.40

BTC/USD

61,404.00 Price
-2.720% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading